2005
DOI: 10.3892/ijo.26.4.1053
|View full text |Cite
|
Sign up to set email alerts
|

Aberrant expressions of annexin A10 short isoform, osteopontin and α-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
22
0

Year Published

2008
2008
2014
2014

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 19 publications
(26 citation statements)
references
References 0 publications
4
22
0
Order By: Relevance
“…This study also showed that annexin A10 was down‐regulated in HCCs and was associated with a poor prognosis 72. Reduced expression of the short form of annexin A10 in hepatocellular carcinoma has been confirmed in a larger series of hepatocellular carcinomas 73.…”
Section: Individual Annexins and Tumour Development And Progressionsupporting
confidence: 52%
“…This study also showed that annexin A10 was down‐regulated in HCCs and was associated with a poor prognosis 72. Reduced expression of the short form of annexin A10 in hepatocellular carcinoma has been confirmed in a larger series of hepatocellular carcinomas 73.…”
Section: Individual Annexins and Tumour Development And Progressionsupporting
confidence: 52%
“…It is reasonable to suggest that ANXA10 will exhibit unique tissue expression and function distinct from the ANX family. Its shorter, splicing variant, ANXA10S, which was previously mistaken as ANXA10, 25 was specifically expressed in the liver 26 . In the present study, we demonstrated that ANXA10 is a nuclear protein specifically expressed in the mucus cells of the gastric mucosa surface and foveolae, and Brunner's glands in humans and animals, including woodchucks, minipigs, and mice, but not in any other tissues.…”
Section: Discussionsupporting
confidence: 45%
“…Through the mRNA differential display screening and gene expression analysis, we showed that ANXA10 was expressed in a tissue‐restricted pattern and was limited to the liver and stomach 25 . Subsequently, we cloned an amino terminal‐truncated, shorter splicing variant lacking the first five exons, designated as ANAXA10's liver‐specific short isoform or ANXA10S (AY626137) 26 . ANXA10S, 26 which was previously mistaken as ANXA10, 25 was specifically expressed in the liver, and downregulated in HCC associated with tumor progression and poor prognosis 25,26 .…”
Section: Introductionmentioning
confidence: 99%
“…33,35 In this study, we demonstrated for the first time that in patients with resectable HCCs, the HCCs with HNF1β expression were associated with a significantly lower 5-year survival rate than those without HNF1β expression. Most importantly, the prognostic implications of HNF1β expression were independent of the tumor stage.…”
Section: Discussionmentioning
confidence: 87%